Biography

I earned my bachelors degree in Psychology from Boston University, where I made the Deans list and was a member of Psi Chi, the International Honor Society in Psychology. I went on to earn my Doctoral degree in Behavioral Neuroscience from the Boston University School of Medicine, where I trained in the Department of Neurology under the supervision of Drs. Robert G. Feldman MD Professor and Chair, Department of Neurology and Raymon Durso MD, Director, Neuropharmacology Laboratory, VA Healthcare System. I subsequently completed a three year National Institutes of Aging funded Post Doctoral Fellowship in the Biochemistry of Aging under the guidance of Dr. David H. Farb in the Department of Pharmacology and Experimental Therapeutics at the Boston University School of Medicine. My extensive training, first at the bedside in the Department of Neurology, and then at the bench in the Department of Pharmacology and Experimental Therapeutics at the BUSM has provided me with genuine translational research experience in clinical and basic neuroscience and neurotoxicology. I am currently using cutting edge in vivo electrophysiological techniques to study chemical-induced changes in neural network activity in an effort to identify novel therapeutics for age-related neurodegenerative diseases.

Primary Affiliation: Department of Pharmacology and Experimental Therapeutics,Boston University School of Medicine - Boston, Massachusetts , United States

Specialties: Toxicology, Neurology, Pharmacology

Research Interests: Toxicology, Neurotoxicology, Neurodegenerative Disease, Drug Discovery

Education
  • 2007
    NIH/NIA Post Doctoral Fellowship Boston University School of Medicine
  • 2004
    PhD Boston University School of Medicine
  • 1995
    BA Boston University
Relevant Experience
  • 2017
    Board Eligible in Toxicology

Publications

Understanding of the role of manganese in parkinsonism and Parkinson disease.
Neurology 2017 Jan 28;88(4):338-339. Epub 2016 Dec 28.
From the Laboratory of Molecular Neurobiology (M.H.R.), Department of Pharmacology & Experimental Therapeutics, Boston University School of Medicine, MA; and Department of Environmental Health Sciences (E.F.), School of Public Health, University at Albany, Rensselaer, NY.

Combined administration of levetiracetam and valproic acid attenuates age-related hyperactivity of CA3 place cells, reduces place field area, and increases spatial information content in aged rat hippocampus.
Hippocampus 2015 Dec 14;25(12):1541-55. Epub 2015 Jul 14.
Laboratory of Molecular Neurobiology, Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, Massachusetts.

OF